CAV1 deficiency significantly attenuated diabetes-induced cardiac systolic dysfunction and myocardial injury (Figure 2), and that cardiac-specific overexpression of CAV1 accelerated the progression of DCM (Figure 3). The gene discussed is CAV1; the disease is diabetes mellitus.